The use of injectable subcutaneous terbutaline and topical nitroglycerin ointment in the treatment of peripheral vasopressor extravasation in 3 dogs.
local tissue injury
nitroglycerin
noradrenaline
norepinephrine
terbutaline
Journal
Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)
ISSN: 1476-4431
Titre abrégé: J Vet Emerg Crit Care (San Antonio)
Pays: United States
ID NLM: 101152804
Informations de publication
Date de publication:
20 Jun 2024
20 Jun 2024
Historique:
revised:
30
04
2023
received:
22
08
2022
accepted:
12
05
2023
medline:
20
7
2024
pubmed:
20
7
2024
entrez:
20
7
2024
Statut:
aheadofprint
Résumé
To describe the clinical course and treatment of 3 dogs with peripheral vasopressor extravasation. Although vasopressor extravasation (VE) is a well-documented complication in human medicine, literature describing VE and its management in veterinary patients is sparse. VE increases patient morbidity by causing local tissue injury and necrosis. The gold standard treatment for VE, phentolamine, has been periodically limited in supply in human medicine and is not consistently available for use in veterinary medicine. An alternative protocol proposed for use in people with VE combines topical nitroglycerin application with subcutaneous terbutaline infiltration. In this report, a treatment protocol utilizing these therapies was used to treat 3 dogs with VE and secondary tissue injury. This report describes 3 cases of VE-induced tissue injury in dogs. In addition, this report describes the use of perivascular terbutaline infiltration and topical nitroglycerin application as therapeutic management for VE in dogs.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Journal of Veterinary Emergency and Critical Care published by Wiley Periodicals LLC on behalf of Veterinary Emergency and Critical Care Society.
Références
Ricard JD, Salomon L, Boyer A, et al. Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med. 2013;41(9):2108‐2115.
Campbell MT, Macintire DK. Catheterization of the venous compartment. In: Burkitt Creedon JM, Davis H, eds. Advanced Monitoring and Procedures for Small Animal Emergency and Critical Care. 1st ed. Wiley‐Blackwell; 2012:49‐68.
Giuffrida DJ, Bryan‐Brown CW, Lumb PD, et al. Central vs peripheral venous catheters in critically ill patients. Chest. 1986;90(6):806‐809.
Delaney A, Finnis M, Bellomo R, et al. Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study. Emerg Med Australas. 2020;32(2):210‐219.
David V, Christou N, Etienne P, et al. Extravasation of noncytotoxic drugs. Ann Pharmacother. 2020;54(8):804‐814.
Plum M, Moukhachen O. Alternative pharmacological management of vasopressor extravasation in the absence of phentolamine. P T. 2017;42(9):581‐592.
Close AS, Frackelton WH, Kory RC. Cutaneous necrosis due to norepinephrine: II. Mechanism and prevention. Ann Surg. 1958;147(1):44‐50.
Hoff JV, Beatty PA, Wade JL. Dermal necrosis from dobutamine. N Engl J Med. 1979;300(22):1280.
Ruffolo RR, Yaden EL. Vascular effects of stereoisomers of dobutamine. J Pharmacol Exp Ther. 1983;224(1):46‐50.
Tian DH, Smyth C, Keijzers G, et al. Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas. 2020;32(2):220‐227.
Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care. 2015;30(3):653.e9‐653.e17.
Nguyen TT, Surrey A, Barmaan B, et al. Utilization and extravasation of peripheral norepinephrine in the emergency department. Am J Emerg Med. 2021;39:55‐59.
Delgado T, Wolfe B, Davis G, et al. Safety of peripheral administration of phenylephrine in a neurologic intensive care unit: a pilot study. J Crit Care. 2016;34:107‐110.
Medlej K, Kazzi AA, El Hajj Chehade A, et al. Complications from administration of vasopressors through peripheral venous catheters: an observational study. J Emerg Med. 2018;54(1):47‐53.
Lewis T, Merchan C, Altshuler D, et al. Safety of the peripheral administration of vasopressor agents. J Intensive Care Med. 2019;34(1):26‐33.
Cardenas‐Garcia J, Schaub KF, Belchikov YG, et al. Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med. 2015;10(9):581‐585.
Material and Safety Data Sheet: Terbutaline Sulfalte Injection, USP. West Ward Pharmaceuticals; 2019. Accessed November 15, 2022. https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/MSDS_9WEST_TERBUTALINE_SULF_SDV_1MG.pdf
Nickel B. Peripheral intravenous administration of high‐risk infusions in critical care: a risk‐benefit analysis. Crit Care Nurse. 2019;39(6):16‐28.
Norepinephrine. Lexi‐Drugs. Lexicomp; 2022. Accessed November 24, 2022. http://online.lexi.com/
Noradrenaline (norepinephrine) 1 mg/ml concentrate for solution for infusion: summary of product characteristics (SmPC). In: The Electronic Medicines Compendium (EMC). Datapharm; 2020. Accessed January 2, 2022. https://www.medicines.org.uk/emc/product/4115/
Tremblay M, Lessard MR, Trépanier CA, et al. Stability of norepinephrine infusions prepared in dextrose and normal saline solutions. Can J Anaesth. 2008;55(3):163‐167.
Walker SE, Law S, Garland J, et al. Stability of norepinephrine solutions in normal saline and 5% dextrose in water. Can J Hosp Pharm. 2010;63(2):113‐118.
Parameswaran N, Hamlin RL, Nakayama T, et al. Increased splenic capacity in response to transdermal application of nitroglycerine in the dog. J Vet Intern Med. 1999;13:44‐46.
Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33(3):1127‐1140.